Litcius/Paper detail

OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)

Kim Lauper, Denis Mongin, Sytske Anne Bergstra, D. Choquette, Cătălin Codreanu, Diederik De Cock, Lene Dreyer, Ori Elkayam, Kimme L Hyrich, Florenzo Iannone, Nevsun İnanç, E. Kristianslund, T.K. Kvien, B.F. Leeb, G. Lukina, Dan Nordström, Karel Pavelká, Manuel Pombo‐Suárez, Žiga Rotar, María José Santos, Anja Strangfeld, D. Courvoisier, Axel Finckh

2020Annals of the Rheumatic Diseases31 citationsDOIOpen Access PDF

Topics & Concepts

AbataceptMedicineRheumatoid arthritisTNF inhibitorTofacitinibMethotrexateArthritisInternal medicineImmunologyPharmacologyOncologyAdalimumabRituximabAntibodyCytokine Signaling Pathways and InteractionsSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and Therapies
OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY) | Litcius